文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

多中心观察性研究评估脓毒性休克患者抗生素联合治疗与单药治疗的结局

A Multicenter Observational Study Evaluating Outcomes Associated With Antibiotic Combination Versus Monotherapy in Patients With Septic Shock.
PubMed 文献 · Crit Care Explor · 2021-05-12
一句话结论两中心回顾性观察显示,脓毒性休克患者抗生素联合治疗与住院死亡率无显著关联(校正后OR 0.88,95%CI 0.68-1.15)。

该回顾性观察研究纳入澳大利亚布里斯班皇家妇女医院和丹麦哥本哈根Rigshospitalet两个三级ICU中接受抗生素治疗≥72小时且血管升压药治疗≥24小时的成年脓毒性休克患者,比较联合抗生素治疗(两类及以上不同类别抗生素,起始间隔12小时内且重叠使用≥12小时)与单药治疗对住院死亡率的影响。共纳入1667例患者,953例(57%)接受联合治疗;联合治疗组年龄更大(60±16 vs 56±18岁)、Rigshospitalet入院比例更高(58% vs 16%)、APACHE II评分更高(26±8 vs 23±8)。单因素分析中联合治疗与死亡率升高相关(OR=1.33;95%CI 1.07-1.66),但校正年龄、性别、中心、APACHE II评分和慢性健康评估后无显著关联(OR=0.88;95%CI 0.68-1.15)。作者结论认为联合治疗与住院死亡率无关联,两中心间的大差异可能反映当地传统和缺乏确定性证据。

要点

  • 在1667例脓毒性休克患者中,校正年龄、性别、中心、APACHE II评分和慢性健康评估后,联合抗生素治疗与住院死亡率无显著关联(OR=0.88;95%CI 0.68-1.15)。
  • 单因素分析中联合治疗与住院死亡率升高相关(OR=1.33;95%CI 1.07-1.66),但校正后关联不再显著。
  • 联合治疗组患者年龄更大(60±16 vs 56±18岁)、APACHE II评分更高(26±8 vs 23±8)、Rigshospitalet入院比例更高(58% vs 16%)。
  • 联合抗生素治疗定义为使用两类及以上不同类别抗生素、起始间隔在12小时内且重叠使用时间≥12小时。
  • 两中心联合治疗使用比例差异大(Rigshospitalet 58% vs 布里斯班皇家妇女医院 16%),作者认为可能反映当地传统和缺乏确定性证据。

适用人群与场景

  • 两个三级ICU(澳大利亚布里斯班皇家妇女医院和丹麦哥本哈根Rigshospitalet)的成年脓毒性休克患者,接受抗生素治疗≥72小时且血管升压药治疗≥24小时。

诊断标准与关键阈值

  • 联合抗生素治疗定义:使用两类及以上不同类别抗生素,起始间隔在12小时内,且重叠使用时间≥12小时。

研究设计与关键结果

  • 研究类型:回顾性观察性研究;纳入1667例患者,953例(57%)接受联合治疗。
  • 联合治疗组与单药治疗组比较:年龄60±16 vs 56±18岁;Rigshospitalet入院比例58% vs 16%;APACHE II评分26±8 vs 23±8。
  • 单因素分析:联合治疗与住院死亡率升高相关(OR=1.33;95%CI 1.07-1.66)。
  • 校正年龄、性别、中心、APACHE II评分和慢性健康评估后:联合治疗与住院死亡率无显著关联(OR=0.88;95%CI 0.68-1.15)。

证据类型、等级与局限

  • 证据类型:回顾性观察性研究;局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:在本回顾性研究中,联合抗生素治疗与住院死亡率无关联;两中心间的大差异可能反映当地传统和缺乏确定性证据。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To explore the association between antibiotic combination therapy and in-hospital mortality in patients with septic shock in two tertiary ICUs in different countries.

DESIGN: Retrospective observational study.

SETTING: ICUs of two tertiary hospitals, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia, and Rigshospitalet, Copenhagen, Denmark.

PATIENTS: Adult patients with antibiotic treatment greater than or equal to 72 hours and vasopressor therapy greater than or equal to 24 hours.

INTERVENTION: Combination versus mono antibiotic therapy.

MEASUREMENTS AND MAIN RESULTS: Combination antibiotic therapy was defined as receiving two or more antibiotics from different classes, started within 12 hours of each other and with an overlapping duration of greater than or equal to 12 hours. Bivariate and multiple logistic regression analysis were performed comparing combination antibiotic therapy versus antibiotic monotherapy on in-hospital mortality. The analysis was adjusted for age, gender, centre, Acute Physiology and Chronic Health Evaluation II score, and chronic health evaluation. In total, 1,667 patients were included with 953 (57%) receiving combination therapy. Patients given combination therapy were older (60 ± 16 vs 56 ± 18), more likely admitted to Rigshospitalet (58% vs 16%), and had a higher Acute Physiology and Chronic Health Evaluation II score (26 ± 8 vs 23 ± 8). Combination therapy was associated with an increased mortality in univariate analysis (odds ratio = 1.33; 95% CI, 1.07-1.66); however, there was no significant association in the adjusted analysis (odds ratio = 0.88; 95% CI, 0.68-1.15).

CONCLUSIONS: In this retrospective study, no association was found between use of combination therapy and in-hospital mortality. The large differences between centers probably reflect local traditions and lack of definitive evidence.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Torisson G, Bruun Madsen M, Schmidt Davidsen A, et al. A Multicenter Observational Study Evaluating Outcomes Associated With Antibiotic Combination Versus Monotherapy in Patients With Septic Shock. Crit Care Explor. 2021. PMID: 34079939. doi:10.1097/CCE.0000000000000383

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。